VDR and infection: Notably, despite using BCG (not Mtb), our short-term cellular/mouse infection models clearly demonstrated that MIR337-3p reduced macrophage VDR antimicrobial response, leading to enhanced BCG entry/replication/infection in cells as well as the ability of innate cell populations to mount fast-acting immunity.